Your Gateway to Global News
News Updates
Do not worry we don't spam!
World
Jazz Pharmaceuticals has posted fresh phase 2 data on zanidatamab that show the HER2-targeted bispecific antibody kept 59% of people...
Business
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has taken a significant step in its financial strategy, announcing a private offering of $850...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has announced its participation in two upcoming investor conferences in September 2024. The company will...
Jazz Pharmaceuticals, a global biopharmaceutical company, recently announced top-line results from a Phase 3 trial in Japan evaluating cannabidiol oral...
Stay Tuned With Updates
